Dengue fever laboratory tests

Dengue Fever Microchapters
Home
Patient Info
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Dengue fever from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dengue fever laboratory tests On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dengue fever laboratory tests All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dengue fever laboratory tests
CDC on Dengue fever laboratory tests
Dengue fever laboratory tests in the news
Blogs on Dengue fever laboratory tests
Directions to Hospitals Treating Dengue fever
Risk calculators and risk factors for Dengue fever laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alonso Alvarado, M.D. [2]

Overview

The earliest abnormality in the complete blood count is decreased white cell count, which usually occurs during the febrile phase. Leukopenia should alert the physician to a high probability of dengue. The platelet count usually begins to drop when the temperature is returning to normal and is followed by findings indicative of plasma leakage such as elevated hematocrit level and hypoproteinemia. However, the extent of hemoconcentration may be affected by dilutional effect from excessive fluid administration or significant hemorrhage from the gastrointestinal tract and white cell count may increase as a result of stress response. Serology and virology tests are used to confirm the diagnosis of dengue virus infection.

Laboratory Findings

Adapted from Dengue: guidelines for diagnosis, treatment, prevention and control. © World Health Organization 2009

Complete Blood Count

• Progressive leukopenia (≤5000 cells/mm³) is the earliest laboratory abnormality in dengue virus infeciton. It is usually followed by an abrupt decline in platelet count to about 100,000 cells/mm³ before the emergence of signs of plasma leakage.

• Plasma leakage is heralded by a rising hematocrit above the baseline. The extent of hemoconcentration reflects the severity of plasma leakage. However, this may be abated by excessive intravenous fluid administration or significant hemorrhage from the gastrointestinal tract. Frequent hematocrit determinations are essential for guiding intravenous fluid therapy.

• The hematocrit level normalizes or may be lower than the baseline due to the dilutional effect. White cell count usually starts to rise soon after defervescence, while the recovery of the platelet count is typically delayed.

Metabolic Panel

• Hypoproteinemia, accompanied by fluid accumulation such as pleural effusions or ascites, may be evident.

• Metabolic acidosis, electrolyte disturbances, and abnormalities suggestive of organ dysfunction (including elevated aspartate transaminase, alanine transaminase, blood urea nitrogen, and creatinine) may occur as a result of tissue hypoperfusion associated with prolonged shock.

Laboratory Diagnostics

Virology and Serology Tests

• A diagnosis of confirmed dengue infection is established by isolation of the virus, detection of viral genome or NS1 antigen, or seroconversion of IgM or IgG (from negative to positive IgM/IgG or fourfold increase in the specific antibody titer) in paired sera.

• A positive IgM serology or a hemagglutination inhibition assay (HIA) antibody titer of 1280 or higher (or comparable figures by ELISA in a single specimen), are diagnostic of a probable dengue infection. Both probable and confirmed dengue cases should be notified to health authorities.

Definition	Method†	Interpretation†	Sample Characteristics
Confirmed Dengue Infection	Viral isolation	Virus isolated	Serum (collected at 1–5 days of fever) or necropsy tissues
	Genome detection	Positive RT-PCR or positive real-time RT-PCR
	Antigen detection	Positive NS1 Ag
		Positive immunohistochemical	Necropsy tissues
	IgM seroconversion	From negative IgM to positive IgM in paired sera	Acute serum (days 1–5) and convalescent serum (15–21 days after first serum)
	IgG seroconversion	From negative IgG to positive IgG in paired sera or 4-fold increase IgG levels among paired sera
Probable Dengue Infection	Positive IgM	Positive IgM	Single serum collected after day 5
	High IgG levels	High IgG levels by ELISA or hemagglutination inhibition assay (≥1280)

   ^† ELISA = enzyme-linked immunosorbent assay; IgG = immunoglobulin G; IgM = immunoglobulin M; NS1 Ag = non-structural protein 1 antigen; RT-PCR = reverse transcriptase polymerase chain reaction